Pregabalin (Lyrica) for the Treatment of Restless Legs Syndrome
Status:
Withdrawn
Trial end date:
2008-05-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the safety and efficacy of Pregabalin (Lyrica) in treating patients
with Restless Legs Syndrome (RLS) in a double-blind, placebo-controlled trial.